AK7 (Adenylate Kinase 7) is a member of the adenylate kinase (AK) family of enzymes, which play a crucial role in cellular energy metabolism. Adenylate kinases are involved in the regulation of adenine nucleotide composition within the cell and in the interconversion of adenine nucleotides. Specifically, they catalyze the transfer of a phosphate group from ATP to AMP, forming two molecules of ADP, a reaction important in maintaining the energy balance within the cell.The AK7 enzyme is distinct from other adenylate kinases in terms of its tissue distribution, structure, and specific function. It is predominantly expressed in ciliated cells of the lung and respiratory tract. The unique localization of AK7 suggests its specialized role in these tissues, possibly related to ciliary movement and function. Cilia are essential for various functions, including mucociliary clearance in the respiratory tract, where they help to remove mucus and trapped particles.
Structurally, AK7 shares the characteristic nucleotide-binding domain of adenylate kinases but also has unique features that differentiate it from other family members. These distinctions are likely related to its specialized functions in specific cell types. Mutations in the AK7 gene have been linked to certain pathological conditions, particularly primary ciliary dyskinesia (PCD), a disorder characterized by chronic respiratory tract infections and impaired ciliary function. This association underscores the importance of AK7 in ciliary movement and respiratory health.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
An AMPK activator, influencing energy metabolism pathways, potentially affecting AK7. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
An AMPK activator, commonly used for its metabolic effects, which could indirectly influence AK7 activity. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $92.00 | 1 | |
Known to activate AMPK and modulate energy metabolism, potentially impacting AK7. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Influences metabolic pathways and has been shown to activate AMPK, potentially affecting AK7. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
A glucose analog that interferes with glycolysis, potentially affecting energy metabolism and AK7 activity. | ||||||
Coenzyme Q10 | 303-98-0 | sc-205262 sc-205262A | 1 g 5 g | $71.00 $184.00 | 1 | |
Involved in the mitochondrial electron transport chain, potentially influencing energy balance and AK7 activity. | ||||||
Nicotinamide riboside | 1341-23-7 | sc-507345 | 10 mg | $411.00 | ||
A precursor of NAD+, known to influence cellular metabolism and energy homeostasis, potentially impacting AK7. | ||||||
Creatine, anhydrous | 57-00-1 | sc-214774 sc-214774A | 10 mg 50 g | $28.00 $79.00 | 2 | |
Involved in energy storage and metabolism, could indirectly affect AK7 activity. | ||||||
α-Lipoic Acid | 1077-28-7 | sc-202032 sc-202032A sc-202032B sc-202032C sc-202032D | 5 g 10 g 250 g 500 g 1 kg | $69.00 $122.00 $212.00 $380.00 $716.00 | 3 | |
Known to influence mitochondrial function and energy metabolism, potentially impacting AK7. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
A PPAR alpha agonist, influencing lipid metabolism and potentially AK7 activity. | ||||||